augmentin 875/125 NATRECOR has been studied in a broad range of patients, including the elderly 53 65 years of age, women 33, minorities 17 black, and patients with a history of significant morbidities such as hypertension 71, previous myocardial infarction 38, diabetes 43, atrial fibrillation flutter 37, ventricular tachycardia fibrillation 10, and preserved systolic function 20